Photon or Proton Therapy for Adolescent and Young Adult Tumors Focused on Long-Term Survivors.
adolescent and young adult
aya
proton beam therapy
radiotherapy
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
22 Apr 2021
22 Apr 2021
Historique:
entrez:
31
5
2021
pubmed:
1
6
2021
medline:
1
6
2021
Statut:
epublish
Résumé
Background This study was conducted to evaluate late toxicities in adolescent and young adult (AYA) patients who received photon or proton therapy. Methodology A total of 106 AYA patients who received proton and photon therapy and were followed-up for more than two years were retrospectively evaluated. The median age of patients was 22 years (range, 15-29 years). A total of 47 patients were male and 59 were female. A total of 35 and 71 patients received photon and proton therapy, respectively. All but one patient received radiotherapy with curative intent. The target disease was benign and malignant in 28 and 78 patients, respectively. Results The median follow-up period in all patients was 62 months (range: 24-293 months). Grade 3 or higher toxicity was observed in 20 patients. There was one case of grade 5 toxicity (myelodysplastic syndrome), which was probably due to chemotherapy. No other secondary cancers were observed. Regarding life events, 15 and 88 patients were married and unmarried at the start of radiotherapy, respectively. Of the 88 unmarried patients, five were married after radiotherapy. Occupation and education were evaluated in 71 patients. Of the 71 patients, 33 were students, 21 were employed, and 16 were unemployed. Of the 33 students, eight were employed and 11 were at a higher educational grade after radiotherapy. Of the 21 employed patients, 17 had the same jobs and four had lost their jobs after radiotherapy. For the 16 unemployed patients, all remained unemployed. Conclusions This study is one of the largest studies to focus on life after radiation therapy among AYAs and suggests that cancer treatment has an influence on life events.
Identifiants
pubmed: 34055504
doi: 10.7759/cureus.14627
pmc: PMC8144073
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e14627Informations de copyright
Copyright © 2021, Mizumoto et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Cancer. 2018 Jan 1;124(1):136-144
pubmed: 28902390
Cancer Sci. 2017 Mar;108(3):444-447
pubmed: 28004469
Psychooncology. 2019 Apr;28(4):675-686
pubmed: 30703261
Pediatr Blood Cancer. 2020 Dec;67(12):e28664
pubmed: 32881313
Support Care Cancer. 2019 Jul;27(7):2609-2616
pubmed: 30467794
Cancer Med. 2016 Jul;5(7):1519-25
pubmed: 27165972
Support Care Cancer. 2016 Nov;24(11):4689-96
pubmed: 27387913
Support Care Cancer. 2018 May;26(5):1479-1487
pubmed: 29168035
Neurol Med Chir (Tokyo). 2017 Jul 15;57(7):343-355
pubmed: 28603224
Gynecol Oncol. 2018 Jun;149(3):464-469
pubmed: 29588102
Nat Rev Cancer. 2008 Apr;8(4):288-98
pubmed: 18354417
J Adolesc Young Adult Oncol. 2015 Dec;4(4):192-9
pubmed: 27077153
Health Psychol. 2013 Jun;32(6):695-705
pubmed: 23088176
J Adolesc Young Adult Oncol. 2018 Nov 16;:
pubmed: 30452301